Ohio

Overview

Ohio operates parallel medical and adult-use cannabis programs, both run by the Division of Cannabis Control within the Department of Commerce. The Ohio Medical Marijuana Control Program was established by House Bill 523 (2016), signed by Governor John Kasich, and launched sales on January 16, 2019.

Adult-use cannabis was legalized by Issue 2 of November 7, 2023 (a voter-initiated statute that passed 57–43%). The law took effect December 7, 2023, and the first retail sales began August 6, 2024.

Adult-use (Issue 2)

• Public possession: 2.5 oz flower; 15 g concentrate.
• Home cultivation: 6 plants per adult; maximum 12 plants per household.
• Tax allocation (Issue 2 statutory formula):
  • 36% to social-equity and jobs programs
  • 36% to municipalities with licensed dispensaries
  • 25% to education and substance-abuse initiatives
  • 3% to administrative costs

Medical program (HB 523)

Qualifying conditions

The Ohio Medical Marijuana Control Program covers 25+ conditions, including cancer, epilepsy, PTSD, chronic and severe pain, Alzheimer's, ALS, Crohn's disease, Tourette syndrome, IBD, MS, sickle-cell disease, Parkinson's, glaucoma, HIV/AIDS, fibromyalgia, hepatitis C, traumatic brain injury, opioid use disorder, terminal illness, and others. The State Medical Board of Ohio adds conditions periodically through public petitions and rulemaking.

Product forms and limits

• Approved forms: edibles, oils, vapor, transdermal patches, tinctures, and plant material (flower) for vaporization. Smoking is explicitly prohibited; flower must be vaporized.
• Patient possession: up to a 90-day supply as certified by the recommending physician; supplies are tiered by THC potency.
• Home cultivation: prohibited for medical patients. They must purchase from licensed dispensaries.
• Reciprocity: Ohio does not formally recognize out-of-state medical cards, but out-of-state patients aged 21+ may purchase from any adult-use retailer.

Patient enrollment

The medical program reported over 410,000 registered patients as of December 2023. Patient counts have shifted with the recreational rollout, typical of states that activate adult-use alongside an existing medical program.

Patients and caregivers

• Patient minimum age: 18. Minor patients under 18 may access medical cannabis only through a designated caregiver (parent or legal guardian) with practitioner certification.
• Caregiver minimum age: 21.
• Caregivers per patient: up to 2 designated caregivers per patient.
• Caregivers per caregiver: a caregiver may serve up to 2 patients.
• Caregiver registration: Ohio Medical Marijuana Registry; criminal background check.

Historical context

• 1975: Ohio decriminalized possession of up to 100 g (minor misdemeanor), one of the earliest decriminalization moves among US states.
• 2015: Issue 3 (an earlier alternative recreational legalization effort) failed 65–35.
• 2016: The state repealed the mandatory driver's-license suspension ("smoke a joint, lose your license") for cannabis offenses.

Patient registration steps

1. Schedule a visit with an Ohio-certified physician willing to recommend cannabis for a qualifying condition. The State Medical Board of Ohio maintains a registry of certifying physicians.
2. The physician submits a recommendation through the State Medical Board portal.
3. The patient applies through the Ohio Medical Marijuana Registry, submits identity documents, proof of Ohio residency, and a current photo. The standard application fee is $50; reduced fees apply for veterans and indigent patients.
4. Approved patients receive an Ohio Patient ID Card valid for one year and renewable. The card authorizes purchases at any licensed Ohio dispensary under medical-program supply caps and tax framework.

Minor patients require a designated caregiver (parent or legal guardian) plus practitioner certification. Caregivers complete a separate application and Ohio Bureau of Criminal Investigation background check.

Reciprocity and visiting patients

Ohio's framework is dual-track for visitors:

• Adult-use: any visitor 21 or older with a government-issued photo ID may purchase from a licensed adult-use retailer under the 2.5 oz / 15 g cap.
• Medical: Ohio does not formally recognize out-of-state medical cards. Visiting medical patients access cannabis through the adult-use retail framework.

The medical-program tax preference is significant for high-volume patients. Visiting medical patients cannot access this preference or the higher 90-day medical supply.

Adult-use rollout timing

Ohio's medical-to-adult-use rollout was unusually fast (under nine months from December 2023 statutory effective date to August 6, 2024 first retail sales). The fast launch was made possible by Ohio's substantial pre-existing medical-dispensary infrastructure: by the time Issue 2 passed, Ohio had 130+ licensed medical dispensaries serving 410,000+ registered patients. The adult-use rollout was largely a regulatory expansion (extending existing licensees' authority to sell to non-medical customers) rather than building a market from scratch.

Employment and workplace

Ohio is an at-will employment state. The Medical Marijuana Control Program statute and Issue 2 preserve broad employer discretion:

• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles as defined by the employer.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level protection.
• No statutory off-duty use protection: neither the medical nor adult-use statute creates a broad "lawful off-duty activity" defense for cannabis use.
• Workers' compensation: post-incident testing positive for THC may result in benefit denial; Ohio Bureau of Workers' Compensation has issued guidance maintaining traditional drug-free workplace incentives.
• Pre-employment testing: Ohio law does not prohibit pre-employment cannabis testing or adverse hiring action based on positive results.

Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure beyond employer discipline.

Hemp-derived intoxicants

Ohio has considered comprehensive restrictions on hemp-derived intoxicating cannabinoids in recent legislative sessions. The 2024 session advanced restrictions on delta-8 THC, delta-10 THC, and similar compounds. Implementation has been uneven; retail availability persists in some channels but is legally contested.

Legislative amendments to Issue 2

Issue 2 was a voter-initiated statute rather than a constitutional amendment, making it subject to legislative amendment by the General Assembly. The 2023-2024 legislative session considered amendments to:

• THC potency caps
• Tax allocation formulas
• Home cultivation parameters
• Public-consumption restrictions

Some amendments were enacted, modifying the Issue 2 framework as originally approved by voters. The Ohio Senate has been the primary venue for amendment proposals.

Recent legislative and regulatory history

Notable developments:

• 1975: decriminalization of small-amount possession (100 g threshold).
• 2015: Issue 3 (alternative adult-use legalization) failed.
• 2016: HB 523 enacted; medical-marijuana program authorized.
• 2019: first licensed medical sales began January 16.
• 2023: Issue 2 (adult-use legalization) approved November 7; effective December 7.
• 2024: first licensed adult-use retail sales began August 6.
• 2025-2026: continued legislative work on Issue 2 amendments, hemp-derived intoxicant rules, and dispensary licensing balance.

The April 2026 federal Schedule III rescheduling order produced no immediate Ohio legislative response; the Division of Cannabis Control issued operator guidance noting state-level licensing and compliance obligations are unchanged.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Wright-Patterson Air Force Base, Naval Operational Support Center Cleveland, Air National Guard installations), and interstate highways. Cuyahoga Valley National Park, Hopewell Culture National Historical Park, and Wayne National Forest fall under federal jurisdiction where cannabis prohibition applies. I-70, I-71, I-75, I-76, I-77, I-80, I-90, and the Ohio Turnpike see active state-patrol and federal drug-interdiction activity. Cross-border purchase patterns with Michigan (adult-use legal), Pennsylvania (medical only), West Virginia (medical only), Kentucky (medical only as of 2025), and Indiana (no legal program) continue to shape consumer flows.